Publikationen, an denen er mitarbeitet Miguel Ángel Sanz Alonso (15)

2023

  1. Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia

    Blood Advances, Vol. 7, Núm. 1, pp. 167-173

  2. Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia

    British Journal of Haematology

2021

  1. Measurable residual disease in elderly acute myeloid leukemia: Results from the PETHEMA-FLUGAZA phase 3 clinical trial

    Blood Advances, Vol. 5, Núm. 3, pp. 760-770

2015

  1. Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: Phase Ib/II panobidara study

    Haematologica, Vol. 100, Núm. 10, pp. 1294-1300

2013

  1. Intravenous Busulfan and Melphalan as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Matched Comparison to a Melphalan-Only Approach

    Biology of Blood and Marrow Transplantation, Vol. 19, Núm. 1, pp. 69-74

2002

  1. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial

    Haematologica, Vol. 87, Núm. 2, pp. 154-166

1999

  1. Primary plasma cell leukemia: Clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics

    Blood, Vol. 93, Núm. 3, pp. 1032-1037

1996

  1. Myelodysplastic syndromes

    Critical Reviews in Oncology/Hematology, Vol. 23, Núm. 1, pp. 57-93

1993

  1. Alternating combination VCMP/VBAP chemotherapy versus melphalan/prednisone in the treatment of multiple myeloma: A randomized multicentric study of 487 patients

    Journal of Clinical Oncology, Vol. 11, Núm. 6, pp. 1165-1171

1992

  1. Increased expression of natural‐killer‐associated and activation antigens in multiple myeloma

    American Journal of Hematology, Vol. 39, Núm. 2, pp. 84-89

1991

  1. Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease

    British Journal of Haematology, Vol. 77, Núm. 2, pp. 185-190

1990

  1. Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors

    British Journal of Haematology, Vol. 75, Núm. 1, pp. 26-33

1989

  1. Predicción de la supervivencia en los síndromes mielodisplásicos. Análisis de dos sistemas de puntuación con valor pronóstico.

    Sangre, Vol. 34, Núm. 1, pp. 41-46

  2. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: A multivariate analysis of prognostic factors in 370 patients

    Blood, Vol. 74, Núm. 1, pp. 395-408

1988

  1. Factores pronósticos en los síndromes mielodisplásicos. Validación de modelos predictivos de supervivencia obtenidos mediante análisis multivariante.

    Sangre, Vol. 33, Núm. 2, pp. 121-126